|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.60 EUR | +2.50% |
|
+4.31% | -11.46% |
| Jan. 20 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
| Jan. 20 | Sector Update: Health Care Stocks Lower in Afternoon Trading | MT |
| Capitalization | 8.3B 9.76B 7.69B 7.19B 13.4B 896B 14.2B 87.89B 34.89B 423B 36.58B 35.83B 1,539B | P/E ratio 2025 * |
-30.4x | P/E ratio 2026 * | -38.4x |
|---|---|---|---|---|---|
| Enterprise value | 7.76B 9.12B 7.19B 6.72B 12.53B 838B 13.28B 82.18B 32.63B 396B 34.2B 33.5B 1,439B | EV / Sales 2025 * |
1,353x | EV / Sales 2026 * | 216x |
| Free-Float |
90.83% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Abivax
More recommendations
More press releases
More news
| 1 day | +2.50% | ||
| 1 week | +4.31% | ||
| Current month | -11.46% | ||
| 1 month | -11.02% | ||
| 3 months | +34.43% | ||
| 6 months | +96.32% | ||
| Current year | -11.46% |
| 1 week | 98.6 |  | 114 |
| 1 month | 94.2 | | 132 |
| Current year | 94.2 | | 132 |
| 1 year | 4.51 | | 132 |
| 3 years | 4.51 | | 132 |
| 5 years | 4.51 | | 132 |
| 10 years | 3.87 | | 132 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2023-05-04 | |
Didier Blondel
DFI | Director of Finance/CFO | - | 2017-01-01 |
Fabio Cataldi
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-07-14 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2022-08-15 | |
Kinam Hong
BRD | Director/Board Member | - | - |
| Chairman | 67 | 2023-05-04 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.50% | +4.31% | +1,676.67% | +1,422.86% | 9.76B | |
| +0.04% | -0.68% | -4.77% | +12.20% | 49.48B | |
| -1.56% | -1.00% | +14.23% | +2.87% | 40.07B | |
| +0.15% | +0.33% | +52.68% | +26.14% | 37.55B | |
| +1.92% | +1.44% | +23.10% | +42.46% | 31.67B | |
| -0.99% | -2.20% | +185.93% | +328.06% | 22.74B | |
| -3.01% | -3.74% | +69.03% | +145.51% | 16.56B | |
| Average | -0.14% | +0.23% | +288.12% | +282.87% | 29.69B | |
| Weighted average by Cap. | -0.20% | -0.06% | +119.19% | +128.93% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.74M 6.74M 5.32M 4.97M 9.26M 620M 9.82M 60.76M 24.12M 293M 25.29M 24.77M 1.06B | 35.83M 42.13M 33.21M 31.04M 57.86M 3.87B 61.33M 380M 151M 1.83B 158M 155M 6.65B |
| Net income | -263M -309M -244M -228M -425M -28.41B -450M -2.79B -1.11B -13.41B -1.16B -1.14B -48.79B | -193M -227M -179M -167M -312M -20.85B -330M -2.04B -812M -9.84B -851M -833M -35.8B |
| Net Debt | -539M -634M -499M -467M -870M -58.21B -922M -5.71B -2.27B -27.48B -2.38B -2.33B -99.97B | -542M -637M -502M -469M -875M -58.55B -928M -5.74B -2.28B -27.65B -2.39B -2.34B -101B |
More financial data
* Estimated data
Employees
67
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-23 | 106.60 € | +2.50% | 82,782 |
| 26-01-22 | 104.00 € | +1.36% | 125,180 |
| 26-01-21 | 102.60 € | -1.16% | 185,808 |
| 26-01-20 | 103.80 € | +2.77% | 380,689 |
| 26-01-19 | 101.00 € | -1.17% | 73,180 |
Real-time Euronext Paris, January 23, 2026 at 11:55 am EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
106.60EUR
Average target price
109.03EUR
Spread / Average Target
+2.28%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABVX Stock
Select your edition
All financial news and data tailored to specific country editions
